Home

Ondartet kindben Trampe teva sec filings Markér oversøisk Kritisk

Teva Pharmaceutical Industries Limited (TEVA) Market Cap (2012-2022) History
Teva Pharmaceutical Industries Limited (TEVA) Market Cap (2012-2022) History

After cost-cutting spree, Teva chief Schultz nabs big pay bump to nearly  $16M | Fierce Pharma
After cost-cutting spree, Teva chief Schultz nabs big pay bump to nearly $16M | Fierce Pharma

Teva Pharmaceuticals and IBM Expand Global Partnership to Enable Drug  Development and Chronic Disease Management with
Teva Pharmaceuticals and IBM Expand Global Partnership to Enable Drug Development and Chronic Disease Management with

Teva Gains 6.4% on Another Opioid Case Settlement - TipRanks.com
Teva Gains 6.4% on Another Opioid Case Settlement - TipRanks.com

Teva lures Lundbeck chief Schultz with $52M package that makes him among  pharma's top paid | Fierce Pharma
Teva lures Lundbeck chief Schultz with $52M package that makes him among pharma's top paid | Fierce Pharma

SEC Subpoena For Teva | The FCPA Blog
SEC Subpoena For Teva | The FCPA Blog

TEVA - Short Interest - Teva Pharmaceutical Industries Ltd. (NYSE) Stock -  Short Squeeze, Borrow Rates
TEVA - Short Interest - Teva Pharmaceutical Industries Ltd. (NYSE) Stock - Short Squeeze, Borrow Rates

Teva Announces Successful Upsize and Pricing of $2,490,000,000 (equivalent)  Sustainability-Linked Senior Notes and the Increase of the Maximum Tender  Amount of its Debt Tender Offer | Business Wire
Teva Announces Successful Upsize and Pricing of $2,490,000,000 (equivalent) Sustainability-Linked Senior Notes and the Increase of the Maximum Tender Amount of its Debt Tender Offer | Business Wire

DEF 14A
DEF 14A

TEVA Institutional Ownership and Shareholders - Teva Pharmaceutical  Industries Ltd. (NYSE) Stock
TEVA Institutional Ownership and Shareholders - Teva Pharmaceutical Industries Ltd. (NYSE) Stock

Bank of New York Mellon Corp Increases Investment in Teva Pharmaceutical  Industries Despite Declining Revenue and FDA Warnings - Best Stocks
Bank of New York Mellon Corp Increases Investment in Teva Pharmaceutical Industries Despite Declining Revenue and FDA Warnings - Best Stocks

US88167AAE10 Institutional Ownership and Shareholders - Teva Pharmaceutical  Fin Neth 10/01/2026 3.150 Bond
US88167AAE10 Institutional Ownership and Shareholders - Teva Pharmaceutical Fin Neth 10/01/2026 3.150 Bond

DEF 14A
DEF 14A

DEF 14A
DEF 14A

As U.S. Domestic Issuer, Teva Reveals Top Stock Owners | Ctech
As U.S. Domestic Issuer, Teva Reveals Top Stock Owners | Ctech

DEF 14A
DEF 14A

Teva Pharmaceutical Industries Limited (TEVA) Company Profile & Overview -  Stock Analysis
Teva Pharmaceutical Industries Limited (TEVA) Company Profile & Overview - Stock Analysis

Teva Investor Relations on the App Store
Teva Investor Relations on the App Store

DEF 14A
DEF 14A

DEF 14A
DEF 14A

DEF 14A
DEF 14A

Stock Forecast Based On a Predictive Algorithm | I Know First |Stock  Forecast: Teva Shares Rally After Buffet Announces His Doubled Position in  Teva Stock
Stock Forecast Based On a Predictive Algorithm | I Know First |Stock Forecast: Teva Shares Rally After Buffet Announces His Doubled Position in Teva Stock

Definitive Proxy Statement
Definitive Proxy Statement

DEF 14A
DEF 14A

TEVA Institutional Ownership and Shareholders - Teva Pharmaceutical  Industries Ltd. (NYSE) Stock
TEVA Institutional Ownership and Shareholders - Teva Pharmaceutical Industries Ltd. (NYSE) Stock

Stock Forecast Based On a Predictive Algorithm | I Know First |Stock  Forecast: Teva Shares Rally After Buffet Announces His Doubled Position in  Teva Stock
Stock Forecast Based On a Predictive Algorithm | I Know First |Stock Forecast: Teva Shares Rally After Buffet Announces His Doubled Position in Teva Stock